|
Drugs controlled by the United Kingdom (UK) Misuse of Drugs Act 1971 are listed in this article. These drugs are known in the UK as ''controlled drugs'', because this is the term by which the act itself refers to them. In more general terms, however, many of these drugs are also controlled by the Medicines Act 1968, there are many other drugs which are controlled by the Medicines Act but not by the Misuse of Drugs Act, and other substances which may be considered drugs (alcohol, for example) are controlled by other laws. The Misuse of Drugs Act sets out three separate categories, Class A, Class B, and Class C. Class A drugs represent those deemed most dangerous, and so carry the harshest punishments. Class C represents those thought to have the least capacity for harm, and so the Act demands more lenient punishment. In reality the potential harm has little bearing on the class,〔benzodiazepines became Class C drugs in 1985, and many cathinones became Class B drugs in 2010. == Class A drugs == 1. The following substances, namely:—〔(【引用サイトリンク】title=Misuse of Drugs Act 1971 (c. 38): SCHEDULE 2: Controlled Drugs )〕 (a) :''N.B. Sub-paragraphs (b) and (c) were added in 1977, sub-paragraphs (d) and (e) were added in 1986. Sub-paragraph (ba) was subsequently added in 2001.〔(【引用サイトリンク】title=The Misuse of Drugs Act 1971 (Modification) Order 2001 )〕'' (b) any compound (not being a compound for the time being specified in sub-paragraph (a) above) structurally derived from tryptamine or from a ring-hydroxy tryptamine by substitution at the nitrogen atom of the side chain with one or more alkyl substituents but no other substituent; (ba) the following phenethylamine derivatives, namely:—〔(【引用サイトリンク】 url = http://isomerdesign.com/Cdsa/scheduleUK.php?schedule=1§ion=30&structure=C )〕 * Allyl(a-methyl-3,4-methylenedioxyphenethyl)amine * 2-Amino-1-(2,5-dimethoxy-4-methylphenyl)ethanol * 2-Amino-1-(3,4-dimethoxyphenyl)ethanol * Benzyl(a-methyl-3,4-methylenedioxyphenethyl)amine * 4-Bromo-b,2,5-trimethoxyphenethylamine * N-(4-sec-Butylthio-2,5-dimethoxyphenethyl)hydroxylamine * Cyclopropylmethyl(a-methyl-3,4-methylenedioxyphenethyl)amine * 2-(4,7-Dimethoxy-2,3-dihydro-1H-indan-5-yl)ethylamine * 2-(4,7-Dimethoxy-2,3-dihydro-1H-indan-5-yl)-1-methylethylamine * 2-(2,5-Dimethoxy-4-methylphenyl)cyclopropylamine * 2-(1,4-Dimethoxy-2-naphthyl)ethylamine * 2-(1,4-Dimethoxy-2-naphthyl)-1-methylethylamine * N-(2,5-Dimethoxy-4-propylthiophenethyl)hydroxylamine * 2-(1,4-Dimethoxy-5,6,7,8-tetrahydro-2-naphthyl)ethylamine * 2-(1,4-Dimethoxy-5,6,7,8-tetrahydro-2-naphthyl)-1-methylethylamine * a,a-Dimethyl-3,4-methylenedioxyphenethylamine * a,a-Dimethyl-3,4-methylenedioxyphenethyl(methyl)amine * Dimethyl(a-methyl-3,4-methylenedioxyphenethyl)amine * N-(4-Ethylthio-2,5-dimethoxyphenethyl)hydroxylamine * 4-Iodo-2,5-dimethoxy-a-methylphenethyl(dimethyl)amine * 2-(1,4-Methano-5,8-dimethoxy-1,2,3,4-tetrahydro-6-naphthyl)ethylamine * 2-(1,4-Methano-5,8-dimethoxy-1,2,3,4-tetrahydro-6-naphthyl)-1-methylethylamine * 2-(5-Methoxy-2,2-dimethyl-2,3-dihydrobenzo()furan-6-yl)-1-methylethylamine * 2-Methoxyethyl(a-methyl-3,4-methylenedioxyphenethyl)amine * 2-(5-Methoxy-2-methyl-2,3-dihydrobenzo()furan-6-yl)-1-methylethylamine * b-Methoxy-3,4-methylenedioxyphenethylamine * 1-(3,4-Methylenedioxybenzyl)butyl(ethyl)amine * 1-(3,4-Methylenedioxybenzyl)butyl(methyl)amine * 2-(a-Methyl-3,4-methylenedioxyphenethylamino)ethanol * a-Methyl-3,4-methylenedioxyphenethyl(prop-2-ynyl)amine * N-Methyl-N-(a-methyl-3,4-methylenedioxyphenethyl)hydroxylamine * O-Methyl-N-(a-methyl-3,4-methylenedioxyphenethyl)hydroxylamine * a-Methyl-4-(methylthio)phenethylamine * b,3,4,5-Tetramethoxyphenethylamine * b,2,5-Trimethoxy-4-methylphenethylamine (c) any compound (not being methoxyphenamine or a compound for the time being specified in sub-paragraph (a) above) structurally derived from phenethylamine an N-alkylphenethylamine, a methylphenethylamine, an N-alkyl-α-methylphenethylamine, an ethylphenethylamine, or an N-alkyl-α-ethylphenethylamine by substitution in the ring to any extent with alkyl, alkoxy, alkylenedioxy or halide substituents, whether or not further substituted in the ring by one or more other univalent substituents. (d) any compound (not being a compound for the time being specified in sub-paragraph (a) above) structurally derived from fentanyl by modification in any of the following ways, that is to say, :(i) by replacement of the phenyl portion of the phenethyl group by any heteromonocycle whether or not further substituted in the heterocycle; :(ii) by substitution in the phenethyl group with alkyl, alkenyl, alkoxy, hydroxy, halogeno, haloalkyl, amino or nitro groups; :(iii) by substitution in the piperidine ring with alkyl or alkenyl groups; :(iv) by substitution in the aniline ring with alkyl, alkoxy, alkylenedioxy, halogeno or haloalkyl groups; :(v) by substitution at the 4-position of the piperidine ring with any alkoxycarbonyl or alkoxyalkyl or acyloxy group; :(vi) by replacement of the N-propionyl group by another acyl group; (e) any compound (not being a compound for the time being specified in sub-paragraph (a) above) structurally derived from pethidine by modification in any of the following ways, that is to say, :(i) by replacement of the 1-methyl group by an acyl, alkyl whether or not unsaturated, benzyl or phenethyl group, whether or not further substituted; :(ii) by substitution in the piperidine ring with alkyl or alkenyl groups or with a propano bridge, whether or not further substituted; :(iii) by substitution in the 4-phenyl ring wiith alkyl, alkoxy, aryloxy, halogeno or haloalkyl groups; :(iv) by replacement of the 4-ethoxycarbonyl by any other alkoxycarbonyl or any alkoxyalkyl or acyloxy group; :(v) by formation of an N-oxide or of a quaternary base. (f) any compound (not being benzyl(α-methyl-3,4-methylenedioxyphenethyl)amine) structurally derived from mescaline, 4-bromo-2,5-dimethoxy-α-methylphenethylamine, 2,5-dimethoxy-α,4-dimethylphenethylamine, N-hydroxytenamphetamine, or a compound specified in sub-paragraph (ba) or (c) above, by substitution at the nitrogen atom of the amino group with a benzyl substituent, whether or not substituted in the phenyl ring of the benzyl group to any extent.”. 2. Any stereoisomeric form of a substance for the time being specified in paragraph 1 above not being dextromethorphan or dextrorphan. 3. Any ester or ether of a substance for the time being specified in paragraph 1 or 2 above (being a substance for the time being specified in Part II of this Schedule ). 4. Any salt of a substance for the time being specified in any of paragraphs 1 to 3 above. 5. Any preparation or other product containing a substance or product for the time being specified in any of paragraphs 1 to 4 above. 6. Any preparation designed for administration by injection which includes a substance or product for the time being specified in any of paragraphs 1 to 3 of Part II of this Schedule. 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Drugs controlled by the UK Misuse of Drugs Act」の詳細全文を読む スポンサード リンク
|